Apertus Pharmaceuticals
About:
Apertus Pharmaceuticals is an API manufacturing company that provides controlled and non-controlled substance APIs.
Website: http://www.apertuspharma.com
Top Investors: BioGenerator
Description:
Apertus Pharmaceuticals is an Active Pharmaceutical Ingredient, or API, manufacturing company targeting dosage form manufacturing companies within the pharmaceutical industry. Apertus Pharmaceuticals provides controlled substance APIs, non controlled substance APIs, and intellectual property to the pharmaceutical market. In addition, Apertus Pharmaceuticals utilizes the philosophies of Green Chemistry as outlined by the FDA and will target higher purity standards than those set by the current standard setting authorities. Apertus is led by CEO Rick Ryan, Ph.D. and CSO David Gindelberger, Ph.D.
$700000
$1M to $10M
St Louis, Missouri, United States
2012-01-01
info(AT)apertuspharma.com
David Gindelberger, Rick Ryan
1-10
2012-01-25
Private
© 2025 bioDAO.ai